Vir Biotechnology
VIR
VIR
164 hedge funds and large institutions have $3.64B invested in Vir Biotechnology in 2021 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 65 increasing their positions, 32 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
0.02% less ownership
Funds ownership: 59.19% → 59.16% (-0.02%)
6% less capital invested
Capital invested by funds: $3.87B → $3.64B (-$235M)
14% less funds holding in top 10
Funds holding in top 10: 7 → 6 (-1)
Holders
164
Holding in Top 10
6
Calls
$29.3M
Puts
$20.6M
Top Buyers
| 1 | +$20.1M | |
| 2 | +$15.3M | |
| 3 | +$15.2M | |
| 4 |
Millennium Management
New York
|
+$13.1M |
| 5 |
State Street
Boston,
Massachusetts
|
+$12.9M |
Top Sellers
| 1 | -$22.7M | |
| 2 | -$14.4M | |
| 3 | -$11.8M | |
| 4 |
Norges Bank
Oslo,
Norway
|
-$10.1M |
| 5 |
N
Natixis
Paris,
France
|
-$8.88M |